Treatment of supraventricular arrhythmias with encainide
- 29 August 1986
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (5) , C55-C57
- https://doi.org/10.1016/0002-9149(86)90105-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Encainide for refractory supraventricular tachycardia in childrenThe American Journal of Cardiology, 1986
- Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1986
- Electrophysiology in assessing supraventricular arrhythmias: Value of programmed stimulation in predicting and understanding efficacy of encainideThe American Journal of Cardiology, 1986
- Assessment of antiarrhythmic drug efficacy in the treatment of supraventricular arrhythmiasThe American Journal of Cardiology, 1986
- Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmiasThe American Journal of Cardiology, 1984
- Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathwayThe American Journal of Cardiology, 1984
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathwayThe American Journal of Cardiology, 1980